Zacks Research Issues Pessimistic Forecast for ACHC Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Stock analysts at Zacks Research cut their Q2 2025 earnings per share estimates for Acadia Healthcare in a research report issued to clients and investors on Wednesday, July 16th. Zacks Research analyst R. Sipani now anticipates that the company will post earnings per share of $0.68 for the quarter, down from their previous estimate of $0.69. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare's Q3 2025 earnings at $0.86 EPS, Q4 2025 earnings at $0.70 EPS, FY2025 earnings at $2.65 EPS, Q1 2026 earnings at $0.47 EPS, Q2 2026 earnings at $0.75 EPS, FY2026 earnings at $2.92 EPS and FY2027 earnings at $3.37 EPS.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. The firm had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. During the same period in the previous year, the business earned $0.84 EPS. The firm's revenue for the quarter was up .3% on a year-over-year basis.

Other analysts have also recently issued research reports about the company. Mizuho cut their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Barclays decreased their price objective on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 14th. Guggenheim assumed coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They set a "buy" rating and a $36.00 price objective on the stock. KeyCorp reduced their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Finally, Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $47.94.

Acadia Healthcare Price Performance

ACHC stock opened at $22.65 on Friday. Acadia Healthcare has a 52-week low of $20.36 and a 52-week high of $82.41. The business has a fifty day moving average of $23.11 and a two-hundred day moving average of $30.32. The stock has a market cap of $2.09 billion, a price-to-earnings ratio of 11.18, a price-to-earnings-growth ratio of 4.32 and a beta of 0.93. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.72.

Institutional Investors Weigh In On Acadia Healthcare

Several institutional investors and hedge funds have recently modified their holdings of ACHC. UMB Bank n.a. raised its position in shares of Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after buying an additional 755 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its position in shares of Acadia Healthcare by 11,218.2% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after buying an additional 1,234 shares during the last quarter. Signaturefd LLC raised its position in shares of Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after buying an additional 1,004 shares during the last quarter. Quadrant Capital Group LLC raised its position in Acadia Healthcare by 287.1% in the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock worth $50,000 after purchasing an additional 933 shares in the last quarter. Finally, State of Wyoming acquired a new position in Acadia Healthcare in the fourth quarter worth about $56,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.